| Menopause |
1 |
1 |
| Hormonal Therapy |
0 |
0.87 |
| Breast Cancer |
0 |
0.37 |
| Uterine Cancer |
0 |
0.27 |
| Cancer |
0 |
0.26 |
| Endometrial Cancer |
0 |
0.23 |
| Lung Cancer |
0 |
0.23 |
| Cancer Pain |
0 |
0.21 |
| Acute Pain |
0 |
0.2 |
| Canada |
0 |
0.2 |
| Colorectal Cancer |
0 |
0.2 |
| Myocardial Infarction (MI) |
0 |
0.18 |
| Thromboembolism |
0 |
0.18 |
| Infarction |
0 |
0.15 |
| Quality of Life |
0 |
0.15 |
| Acute Myocardial Infarction (MI) |
0 |
0.14 |
| Cerebrovascular Accident |
0 |
0.13 |
| Pain Management |
0 |
0.13 |
| Patient Safety |
0 |
0.12 |
| Chronic Pain |
0 |
0.11 |
| Adverse Effects |
0 |
0.1 |
| Board Certification |
0 |
0.1 |
| Estrogen |
0 |
0.1 |
| Pain |
0 |
0.1 |
| Uterus |
0 |
0.1 |
| Atrial Fibrillation |
0 |
0.08 |
| Revenue and Practice Management |
0 |
0.08 |
| Bone Density |
0 |
0.07 |
| Heart Failure (HF) |
0 |
0.07 |